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ABSTRACT 
Background: Health-related quality of life (HRQOL) is an important aspect of diabetes mellitus care. The 
objective of the study was to determine the HRQOL of diabetes mellitus (DM) patients in Botswana as 
little known in Africa.  Materials and methods: A cross-sectional study of 380 randomly selected DM 
patients in a tertiary clinic in Gaborone, Botswana was conducted to obtain Data on HRQOL and 
structured questionnaire was used to collect information on sociodemographic and clinical characteristics. 
Multivariate logistic regression to determine sociodemographic and clinical characteristics associated. 
Results: Majority of patients were female with no formal education or primary level of education. Mean 
HbA1c was 7.97% (SD: 2.02) and most patients had poor glycemic control. The majority had both worse 
physical composite score (PCS-12) and mental composite score (MCS-12), with worse proportions of the 
two. Female JHQGHUROGHUDJH\HDUVand the presence of three or more documented diabetic 
complications were associated with significant worse PCS-12. Presence of two diabetic complications, 
three or more diabetic complications, and musculoskeletal disease were associated with significant MCS-
12. Conclusions: Diabetic patients in Botswana have relatively poor HRQOL. The fact that most patients 
present late with complications calls for policy attention to diagnose diabetes mellitus early and prevent 
associated complications, ultimately improving health-related quality of life among diabetes mellitus 
patients.   
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1. Introduction 
 
Diabetes mellitus (DM) is a disease of global public health importance associated with high morbidity and 
mortality.1,2 According to International Diabetes Federation report of 2015, about 415 million people have 
DM globally with the figure projected to have increased to 642 million by 2040 or maybe even doubled by 
the year 2040.3,4 The greatest increase will be in developing countries (69%) compared with developed 
countries (20%)5, with non-communicable disease (NCDs) accounting for up to 80% of deaths among 
developing countries.6 In Botswana, the prevalence of DM among adults (20-79 years) is approximately 
52 per 1000 people out of which 31.6 per 1000 remain undiagnosed.3  
 
Health-related quality of life (HRQOL) refers to the physical, psychological and social aspects of health 
WKDWDUHLQIOXHQFHGE\SHUVRQ¶VH[SHULHQFHRQEHOLHIVH[SHFWDWLRQVDQGSHUFHSWLRQV8QGHUVWDQGLQJWKHse 
domains by health care workers has an advantage in terms of incorporating chronic disease management 
strategies into routine care, leading to a reduction of both morbidity and mortality, including patients in 
developing countries.7-12  The psychosocial burden of living with diabetes mellitus is considerable as it 
affects self-care behaviors, leading to long term poor glycemic control, increased risk of long-term 
complications and poor quality of life.9,13-15 Understanding the measurements of HRQOL as well as the  
factors associated with poor quality of life has a benefit in terms of improving the physical and 
psychosocial burden associated with DM, ultimately reducing associated costs, morbidity and 
mortality.15,16  
 
Published studies have found that DM patients without complications have higher overall utility values 
than those with complications.17Currently, most of the published literature on HRQOL of patients with DM 
is based on developed countries with little known among developing countries. Whilst it is well 
acknowledged that there is better access to health in developed countries compared to developing 
countries, there are more associated morbidities of DM in developing countries9, which will have a 
considerable impact on their HRQOL.12,18 Consequently, we sought to determine the HRQOL, and 
associated sociodemographic and clinical variables, among patients with DM in Botswana. The findings 
will be used to suggest future strategies in Botswana to improve the management of these patients if 
pertinent. The findings may also be of interest to other African countries with increasing rates of NCDs 
including diabetes. 
 
2. Methods 
 
2.1: Study area, design and participants recruitment 
Details of study area, design and participants recruitment, inclusion and exclusion criteria and how 
sociodemographic and clinical data was collected  have been described in details elsewhere19 , In 
summary, a cross-sectional study was conducted whereby 380 patients were randomly selected for the 
purpose of this study between July to September 2015 in Block 6 clinic, a tertiary unit in Gaborone, 
Botswana, and data was obtained by means of standard structured questionnaire interviews, Further data 
was obtained from patients¶ hospital charts. This clinic was chosen as it offers services to over 3,000 
diabetic patients. In Botswana, medicines are provided free-of-charge to patients; consequently, co-
payment for medicines is not an issue.19 On average 1,800 to 2,000 diabetic patients visit the clinic 
monthly.   
 
2.2: Sample size:     
The sample size was calculated from the formula of descriptive cross-sectional study, i.e. N = Z2 p (100-
p)/d2; where: N = estimated minimum sample size, Z = Standard deviation of 1.96 at 95% confidence 
interval, p = Response rate to the SF-12 quality of life questionnaire in the outpatient clinic20 which was 
44.3%, and d = the margin of error on p, which is approximately 0.05. Consequently, N = 1.96 x 1.96 x 
44.3 x 55.7/25,= 379.   
 
As seen, the estimated minimum sample size was 379 patients. 
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2.3: Study instrument 
The most widely used generic measure of quality of life in studies of people with diabetes mellitus is the 
Medical Outcomes Study (MOS) Short-Form General Health Survey, which has several forms (SF-36, 
SF-20, and SF-12). The MOS instrument includes physical, social and role functioning scales to capture 
behavioral dysfunction, and this instrument has been shown to reflect more subjectively components of 
health and well-being.21   
 
We chose to use Social factor (SF-12) as a tool to measure health related quality of life because it  has 
been shown to be as effective as SF-36. The tool (SF-12), is brief and convenient to use22-27. Whilst we 
did not find studies using SF-12 scores among patients with diabetes mellitus in Botswana,  SF-12 has 
been used several times to assess HRQOL among patients with chronic diseases in the Republic of 
South Africa.28-30 Consequently, in view of the proximity of two countries and both have public healthcare 
systems, we saw it as justifiable to select this tool for our study. Both countries also have a high 
prevalence of Human Immunodeficiency Virus (HIV). In Botswana, over 22% of the adult population have 
HIV, with higher rates especially among women.31 Consequently, considerable opportunity for co-
morbidity of diabetes among these patients. 
 
Specifically, we used the short form of the widely used SF-36 called SF-Y+HDOWK6XUYH\SF-12; 
Quality Metric Inc., Lincoln, RI, USA).  The SF-YLVDEULHIDQGUHOLDEOHPHDVXUHRIRYHUDOOKHDOWK
status.32 It measures eight domains of health; physical functioning, role limitations because of physical 
health (role-physical), bodily pain, general health perceptions, vitality, social functioning, role limitations 
because of emotional problems (role-emotional) and mental health.32 The information is then scored by 
the scale from 0 to 100 on each of the domains, as well as for the Physical Component Summary (PCS-
12) scale and Mental Component Summary (MCS-12).33 We entered the responses of SF-12 for each 
patient into the SF website (www.sf-36.org/SF-12.html). The website computes the scores of PCS-12 and 
MCS-12 into the range 0-100, whereby 0 indicates the lowest composite score and 100 the highest 
composite score.  The outcome variables in our study were; the worse physical composite score and 
worse mental composite score.  
 
We did not conduct separate analysis for Type 1 or Type 2 diabetes, similar to other studies12, as the vast 
majority of patients in Botswana attending clinics such as this one are Type 2. The majority of Type 1 
patients in Botswana continue to attend pediatric and adolescent clinics at the National hospital. 
Consequently, it was perceived that undertaking a separate analysis for the two types of diabetes would 
be difficult to interpret; consequently, we combined these two types of diabetes mellitus for the study. 
However, we did assess the two types of diabetes as an independent variable. 
 
2.4: Dependent variables 
We measured both the worse PCS-12 and worse MCS-12 as a score of <50%, and the better PCS and 
0&6DVWKHVFRUHVRI2XURXWFRPH (dependent) variables were worse PCS-12 and worse MCS-
12.  
 
The choice of 50 % cut off is based on the fact that the scores that are summarized above or equal to 
50% are categorized as better health status and those below 50% are categorized to have a worse health 
status.34-37 
 
2.5: Independent variables 
Our independent sociodemographic variables were; age, gender, marital status and level of education. 
We also measured weight and height to determine the Body Mass Index (BMI). Glycemic control was 
determined by extracting results of within past three months of HbA1c from Integrated Patients 
Management System (IPMS) and defined as good (< 7%) DQGSRRU.  
 
We also calculated the average blood pressure in the last 3 visits, and documented the HIV status as 
recorded either in the SDWLHQWV¶FKDUWVRU,306ZLWKLQWKHSDVW\HDU Other independent variables included 
the duration of suffering from diabetes, type of diabetes, the regimen used to treat the diabetes, presence 
or absence of documented diabetic complications and presence or absence of documented 
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musculoskeletal disease. For the purpose of this study, musculoskeletal disease was categorized as 
diseases of the muscle, bone or joints associated with pain, stiffness and limited mobility and involving or 
affecting gait, arms, legs and spine (GALS).38,39 
 
2.6: Data analysis 
We used the SPSS version 22 statistical software for the analysis calculated the inferential statistics for 
proportions of worse outcomes for both sociodemographic and clinical characteristics. A multivariate 
logistic regression analysis was undertaken to determine the association of worse composite scores (PCS 
or MCS) and the factors which were found to be statistically significant in the bivariate analysis. A p-value 
of less than 0.05 was considered statistically significant. 
 
2.7: Ethical clearance 
The permission to conduct the study was obtained from the University of Botswana Ethics Committee and 
the Institutional Review Board (IRB) and Ethics Committee at Princess Marina Hospital. Ethical clearance 
was secured from the Botswana Ministry of Health Research Unit and all the patients signed informed 
consent.  
 
3. Results 
 
3.1: Sociodemographic and clinical characteristics of study participants 
Details of sociodemographic characteristics and clinical characteristics of the study population have been 
described elsewhere19. In this study, four more patients who were on diet were included in the analysis 
making a total of 380 patients. The majority were female with no formal education or primary level of 
education (Table 1).  
 
Insert Table 1 
 
The mean HbA1c of participants was 7.97% (SD: 2.02) and 60.1% of patients had poor glycemic control 
+E$F. Among the HIV positive patients, 63.6% had CD4 counts above 500 umol/l and mean CD4 
of 641.58 (SD: 302.20). The majority of study participants (57.4%) had uncontrolled hypertension (Table 
1). 
 
3.2: Health-related quality of life of study participants 
The majority of study participants had both worse physical composite score (PCS-12) and mental 
composite score (MCS-12); with worse proportions of the two accounting for 59.7% and 55.3% 
respectively. Likewise, the overall mean scores for both PCS-12 and MCS-12 were below 50% (Table 2). 
 
Insert Table 2 
 
3.3: Association between health-related quality of life and sociodemographic and clinical 
characteristics 
Results of descriptive sociodemographic and clinical groups for PCS-12 and MCS-12 are shown in Table 
3. Factors associated with significant worse PCS-12 in the bivariate analysis were female gender, older 
age, primary or no formal education, being married/divorced/widowed/separated, type of DM, duration of 
DM, presence of DM complications, uncontrolled hypertension and presence documented 
musculoskeletal disease. On the other hand; Body Mass Index (BMI), modality of treatment, glycemic 
control and HIV status were not associated with PCS-12. 
 
As regards MCS-12, the factors associated with significant worse scores included female gender, older 
age, being single/divorced/separated/widowed, the presence of DM complications, HIV status, 
uncontrolled hypertension and the presence of musculoskeletal disease.  
 
Body Mass Index (BMI), duration of DM, modality of treatment and glycemic control were not associated 
with MCS-12 in bivariate analysis (Table 3). 
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Insert Table 3 
 
3.4: Multivariate logistic regression analysis of factors associated with worse Physical Composite 
Score (PCS-12) 
Among the sociodemographic and clinical variables studied, only female gender (p-value = 
0.023,AOR=1.95; 95% CI= 1.09,3.48), ROGHUDJH\HDUVS-value= 0.015,AOR=2.43; 95% CI= 
1.18,4.99). The presence of three or more documented diabetic complications (p-value = 0.002,AOR= 
3.47; 95% CI= 1.56,7.71) were associated with significant worse physical composite scores in multivariate 
analysis (Table 4), 
 
Insert Table 4 
 
 3.5: Multivariate logistic regression analysis of factors associated with worse Mental Composite 
Score (MCS-12) 
In multivariate logistic regression analysis, worse mental health scores were significantly associated with 
the presence of two diabetic complications (p-value = 0.028, AOR=2.40; 95% CI= 1.09, 5.26), three or 
more diabetic complications (p-value = 0.000, AOR=5.37; 95% CI=2.41, 11.96) and the presence of 
documented musculoskeletal disease (p-value = 0.020, AOR=2.52; 95% CI= 1.15, 5.52).  
 
On the other hand, gender, age, level of education, marital status, Body Mass Index, HIV status and 
modality of treatment were not associated with significant worse MCS-12 scores in the multivariate 
analysis (Table 5). 
 
Insert Table 5.  
 
3.6:  Health-related quality of life association among HIV positive patients. 
Results of recent CD4 counts were available for 33/38 (86.8%) of known HIV positive patients. The 
association between CD4 level and HRQOL for both worse PCS-12 and worse MCS-12 did not reveal 
any significance with p-values of 1.00 and 0.46 respectively (Table 6). 
 
Insert Table 6. 
 
4. Discussion 
 
The overall HRQOL of our study participants was worse than the average population (Table 2). This is 
consistent with other studies researching quality of life among diabetic patients.12, 40-43. Most of the 
published studies have shown female gender and older age to be associated with overall worse health-
related quality of life scores.9,16,43-49. These findings are similar to our study for the physical composite 
score (PCS-12) where female gender was significantly associated with worse scores in the multivariate 
analysis (Table 4).  
 
Older age was associated with worse PCS-12 and MCS-12 in the bivariate analysis (Table 3); however, 
during multivariate analysis only worse physical composite score was associated older age in our study 
(Tables 4 and 5), which is similar to findings found elsewhere9,50 Marital status has also been shown to 
influence HRQOL in previous studies. According to Jacobson et al 51 , it has been shown that single and 
married people had better quality of life than those who were divorced/separated. However, a study in 
Greece found contrasting results with being single associated with worse HRQOL.52 In our study, we 
found that being single was associated with better quality of life both for PCS-12 and MCS-12 during 
bivariate analysis (Table 3); however, marital status had no influence on quality of life during multivariate 
analysis (Tables 4 and 5).  
 
Previous studies have shown inconsistent findings of the duration of DM on quality of life, with some 
studies showing that long duration is associated with decreased quality of life16,47,53,54 whilst others 
showed no association.12,55,56 Our study also found no association between duration of DM and HRQOL 
in both PCS-12 and MCS-12 (Tables 4 and 5). The lack of association between duration of DM and 
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quality of life in this study is rather surprising considering the fact that older age, which was significantly 
associated with worse PCS-12 in our study (Table 4), is presumably associated with a longer duration of 
DM. This lack of association could be due to the fact that our study cohort consisted mostly of patients 
diagnosed recently (shorter duration of DM) with complications.  
 
Our study also showed that a lower level of education, namely no formal education and primary 
education, were associated with worse HRQOL outcomes for both PCS-12 and MCS-12 in bivariate 
analysis (Table 3); which is similar to previous studies,16,57. However, the findings in multivariate analysis 
were not significant (Tables 4 and 5).  
 
Higher Body mass index (BMI) has been shown to be associated with a higher number of chronic and 
somatic illnesses and subsequently decreased physical health-related quality of life56.   Most of the 
previous studies have consistently shown that increased BMI is associated negatively with both PCS-
1220,36,58-63 and MCS-12.20,59,62-65 Our study cohort consisted of over 75% of patients who were either 
overweight or obese; however, we did not find any association between HRQOL (both PCS-12 and MCS-
12) and body mass index (Table 3). This lack of association is similar to previous studies 9,66,67. One 
possible reasons may be that overweight and obesity are linked to multifactorial aetiologies such as 
genetic, metabolic, behavioral, social and cultural issues and the SF-12 instrument may not be the most 
sensitive instrument to determine any association between HRQOL and BMI.68,69    
 
The results of previous studies comparing HRQOL and modalities of treatment have produced contrasting 
results. In studies involving both patients with Type 1 and Type 2 DM; the use of insulin injections was 
associated with worse quality of life 20,36,49,68  and patients on combination of oral hypoglycemic agents 
(OHA) and insulin had better quality of life than those on insulin alone in a study of type 2 DM patients.57  
Our study though did not find any association between the modality of treatment and HRQOL. One of the 
possible reason may be that patients with Type 1 and 2 diabetes have different expressions in their 
quality of life and our study only had a limited number 23/380 (6.1%) of patients with Type 1 DM which 
may not be sufficient to detect any changes.  Another study with large sample size of Type 1 DM is 
necessary to provide more conclusive results in this aspect.  
 
Clinically, it can be extrapolated that for diabetes mellitus patients poor glycemic control will be 
associated with both increased prevalence and incidence of macrovascular and microvascular 
complications, ultimately leading decreased HRQOL58,70--72. However, studies have produced contrasting 
results, with some showing poor glycemic control to be associated with worse HRQOL47,54,73 whilst others 
found no association.74-77 Our study did not find an association between glycemic control and HRQOL. 
Previous studies consistently showed that quality of life is negatively associated increased number of 
diabetes mellitus complications.16,36,52,57,74,78,79 Our study also revealed similar findings with number of DM 
complications significantly associated with both worse PCS-12 and MCS-12 (Table 3). 
 
Diabetes mellitus is associated with variety of musculoskeletal diseases; the latter being correlated with 
longer duration of DM and poor metabolic control. Musculoskeletal diseases in DM have been previously 
associated worse HRQOL.39,80,81   We sought to find an association between documented musculoskeletal 
diseases and HRQOL among our study participants. However, whilst we expected that patients with 
musculoskeletal disease to have worse PCS-12, this was not seen. The presence of documented 
musculoskeletal disease was though significantly associated with worse mental composite scores (Table 
5). This needs further investigation to determine how musculosketal disease actual impacts on the quality 
of life of these patients. 
 
Diabetes mellitus and HIV disease are both chronic conditions associated with worse HRQOL in terms of 
physical and mental health status.82,83  As for HIV, lower CD4 is associated with opportunistic infections 
and higher morbidity and mortality.83  Consequently, it was expected that DM patients with coexisting HIV 
disease would have depicted worse HRQOL outcomes. However, we found no association between HIV 
status and HRQOL regardless of CD4 levels (Table 6). Previous studies have shown that being on 
Antiretroviral treatment (ART) regardless of immunosuppression status results in improved health-related 
quality of life scores 84,85. Whilst it was not the intention of this study to determine ART status, all the HIV 
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positive patients in our study were on ART, and their CD4 counts were high (mean CD4= 641.58 umol/l) ± 
Table 1; hence less likelihood of associated HIV conditions. There is a need to carry further studies 
among large cohort of DM patients who are HIV positive to verify our findings. This is particularly 
important given the extra pill burden with these patients, and potential additional impact on adherence. 
 
5. Study limitations 
 
The results of this study are very important; however they need to be interpreted on the background of 
several limitations. Firstly, our study being a cross-sectional study in design; it only provides association 
and not causation. Secondly, though we analyzed both sociodemographic and clinical variables, including 
complications and musculoskeletal disease, we did not assess health behavioral factors such as 
diabetes-self management, alcohol drinking and smoking. These variables might also have had an impact 
on multivariate analysis. Thirdly, our clinic being a tertiary clinic may be presumed to have patients with 
more complications and subsequent worse quality of life outcomes; however, it should be clear that the 
clinic serves in the capacities of primary, secondary and tertiary care making results representative of 
diabetic patients in Botswana. Consequently despite these limitations, we believe our findings are robust 
providing direction for the future to improve the care of these patients. 
 
6. Conclusions 
 
The study findings indicate that diabetic patients in Botswana have relatively poor HQOL affecting both 
physical and mental-well-being. Female gender and older age was associated with worse physical 
composite scores. Musculoskeletal disease was associated with worse mental composite scores. On the 
other hand, increased number of diabetic complications was associated with worse scores for both 
physical and mental composite scores. The fact that most patients present late with complications calls 
for attention to set policies that help diagnose diabetes mellitus earlier and prevent associated 
complications, ultimately improving health-related quality of life among diabetes mellitus patients.  This 
potentially includes programmes around self-management as well medication adherence if this proves to 
be a problem. These are subject areas for the future. 
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Table 1: Socio-demographic and clinical characteristics of study participants 
 Variable Frequency (%) 
Gender 
Male 
Female 
 
116 (30.5%) 
264 (69.5%)  
Age 
Up to 54 
55-64 
65 years and more 
 
159 (41.8%) 
106 (27.9%) 
115 (30.3%) 
Level of education 
No formal education 
Any primary school 
Secondary and above 
 
  70 (18.4%) 
181 (47.6%) 
129 (33.9%) 
Marital status 
Never married 
Currently married 
Others 
 
102 (26.8%) 
157 (41.3%) 
121 (31.8%) 
Body Mass Index 
None obese (< 30kg/m2) 
2EHVHNJP2) 
 
168 (50.0%) 
168 (50.0%) 
Duration of diabetes (years) 
< 5 
5-10 
>10 
 
178 (49.2%) 
  91 (25.1%) 
  93 (25.7%) 
Type of diabetes 
Type 1 
Type 2 
 
  23 (6.1%) 
357 (93.9%) 
Modality of treatment 
Diet 
Oral hypoglycemic agents (OHA) 
Insulin 
Both OHA and Insulin 
 
    4 (1.1%) 
224 (58.9%) 
  51 (13.4%) 
101 (26.6%) 
Glycemic control (HbA1C) 
Normal (< 7%) 
Poor ( 7%) 
 
147 (39.9%) 
221 (60.1%) 
Presence of DM complications 
Yes 
No 
 
311 (81.8%) 
  69 (18.2%) 
HIV status within past 1 year 
Positive 
Negative 
'RQ¶WNQRZ 
 
  38 (10.0%) 
235 (61.8%) 
107 (28.2%) 
CD4 (only for HIV positive)* 
Up to 500 
Over 500 
 
12 (36.4%) 
21 (63.6%) 
Average Blood Pressure (mmHg) 
< 140/90 
 
 
162 (42.6%) 
218 (57.4%) 
14 
 
Presence of musculoskeletal disease 
Yes 
No 
 
  62 (16.4%) 
316 (83.6%) 
*Missing 5 CD4 values 
 
Table 2: Overall health related quality of life 
Variable Frequency (%) Mean ± SD (Range) 
Physical Composite score 
(PCS-12) 
Below average (< 50%) 
$ERYHDYHUDJH 
 
 
227 (59.7%) 
153 (40.3%) 
44.39 ± 10.67 (16.2-63.7) 
Mental Composite score 
(MCS-12) 
Below average (< 50%) 
Above average  
 
 
210 (55.3%) 
170 (44.7%) 
45.96 ± 10.57 (17.4-63.4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
 
 
Table 3: Association of health related quality of life and sociodemographic and clinical 
variables  
Variables  PCS <50% PCS   P-value MCS < 50% 0&6 P-value 
Gender 
Male 
Female 
 
  53 (45.7%) 
174 (65.9%) 
 
63 (54.3%) 
90 (34.1%) 
0.000  
55 (45.4%) 
155 (58.7%) 
   
61 (52.6%) 
109 (41.3%) 
0.041 
Age 
Up to 54 
55-64 
65 years and more 
 
66 (41.5%) 
71 (67.0%) 
90 (78.3%) 
 
93 (58.5%) 
35 (33.0%) 
25 (21.7%) 
0.000  
75 (47.2%) 
52 (49.1%) 
83 (72.2%) 
 
84 (52.8%) 
54 (50.9%) 
32 (27.8%) 
0.000 
Level of 
education 
No formal 
education 
Any primary 
school 
Secondary and 
above 
 
 
 55 (78.6%) 
 
115 (63.5%) 
 
 57 (44.2%) 
 
 
15 (21.4%) 
 
66 (36.5%) 
 
72 (55.8%) 
0.000    
 
46 (65.7%)  
 
109 (60.2%) 
  
55 (42.6%) 
 
 
24 (34.3%) 
 
72 (39.8%) 
 
74 (57.4%) 
0.001 
Marital status 
Never married 
Currently married 
Others 
 
  44 (43.1%) 
100 (63.7%) 
  83 (68.6%) 
 
58 (56.9%) 
57 (36.3%) 
38 (31.4%) 
0.000   
 42 (41.2%) 
  86 (54.8%) 
 82 (67.8%) 
 
60 (58.8%) 
71 (45.2%) 
39 (32.3%) 
0.000 
Body Mass Index 
None obese (< 
30kg/m2) 
Obese NJP2) 
 
  96 (57.1%) 
   
104 (61.9%) 
 
 
72 (42.9%) 
 
64 (38.1%) 
0.374  
90 (53.6%) 
 
97 (57.7%) 
 
78 (46.4%) 
 
71 (42.3%) 
0.442 
Duration of 
diabetes (years) 
< 5 
5-10 
>10 
 
 
90 (50.6%) 
55 (60.4% 
67 (72.0%) 
 
 
88 (49.4%) 
36 (39.6%) 
26 (28.0%) 
0.003  
 
93 (52.2%) 
45 (49.5%) 
61 (65.6%) 
 
 
85 (47.8%) 
46 (50.5%) 
32 (34.4%) 
0.053 
Type of diabetes 
Type 1 
Type 2 
 
    4 (17.4%) 
223 (62.5%) 
 
  19 (82.6%) 
134 (37.5%) 
0.000  
10 (43.5%) 
200 (56.0%) 
 
13 (56.5%) 
157 (44.0%) 
0.241 
Modality of 
treatment 
Oral 
hypoglycemic 
agents (OHA) 
Insulin 
Both OHA and 
Insulin 
 
 
134 (59.8%) 
   
 
26 (51.0%) 
 
  64 (63.4%) 
 
 
90 (40.2%) 
 
 
25 (49.0%) 
 
37 (36.6%) 
0.337      
 
120 (53.6%) 
   
 
28 (54.9%) 
   
59 (58.4%) 
 
 
104 (46.4%) 
 
 
23 (45.1%) 
 
42 (41.6%) 
0.719 
Glycemic control 
(HbA1C) 
Normal (<7%) 
Poor ( 7%) 
 
 
89 (60.5%) 
131(59.3%) 
 
 
 
58 (39.5%) 
90 (40.7%) 
 
0.808  
 
80 (54.4%) 
122 (55.2%) 
 
 
67 (45.6%) 
99 (44.8%) 
0.883 
16 
 
  
Presence of DM 
complications 
Yes 
No 
 
 
205 (65.9%) 
  22 (31.9%) 
 
 
106 (34.1%) 
  47 (68.1%) 
0.000  
 
192 (61.7%) 
  18 (26.1%) 
 
 
119 (38.3%) 
  51 (73.9%) 
0.000 
HIV status within 
past 1 year 
Positive 
Negative 
'RQ¶WNQRZ 
 
 
18 (47.4%) 
140 (59.6%) 
69 (64.5%) 
 
 
20 (52.6%) 
95 (40.4%) 
38 (35.5% 
0.181  
 
15 (39.5%) 
128 (54.5%) 
 67 (62.6%) 
 
 
23 (60.5%) 
107 (45.5%) 
 40 (37.4%) 
0.044 
Average Blood 
Pressure (mmHg) 
< 140/90 
 
 
 
82 (50.6%) 
145 (66.5%) 
 
 
80 (49.4%) 
73 (33.5%) 
0.002  
 
79 (50.6%) 
131 (66.5%) 
 
 
83 (49.4%) 
87 (33.5%) 
0.028 
Presence of 
musculoskeletal 
disease 
Yes 
No 
 
 
 
51 (82.3%) 
174 (55.1%) 
 
 
 
11 (17.7%) 
142 (44.9%) 
0.000  
 
 
51 (82.3%) 
158 (50.0%) 
 
 
 
11 (17.7%) 
158 (50.0%) 
0.000 
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Table 4: Multivariate logistic regression analysis of factors associated with below average 
PCS-12 
Variables Adjusted Odds Ratio (95% CI) P-value 
Gender 
   Male 
   Female 
 
Reference  
1.95 (1.09, 3.48) 
 
 
0.023 
Age in years 
   21-54 
   55-64 
   65 & above 
 
Reference  
1.67 (0.86, 3.22) 
2.43 (1.18, 4.99) 
 
 
0.127 
0.015 
Level of education 
   No formal education 
   Any primary education 
   Secondary and above 
 
2.01 (0.84, 4.84) 
1.10 (0.59, 2.04) 
Reference 
 
0.116 
0.747 
Marital status 
   Never married 
   Currently married 
   Others 
 
Reference  
1.37 (0.70, 2.66) 
1.60 (0.80, 3.20) 
 
 
0.346 
0.182 
BMI 
   Non-obese (< 30kg/m2) 
   2EHVHNJP2) 
 
Reference 
0.97 (0.57, 1.65) 
 
 
0.917 
Type of DM 
Type 1 
Type 2 
 
Reference 
1.38 (0.24-7.78) 
 
 
0.715 
Documented diabetes complications    
   None 
   One  
   Two  
   Three or more  
 
Reference 
1.30 (0.59, 2.86) 
2.14 (0.97, 4.72) 
3.47 (1.56, 7.71) 
 
 
0.511 
0.058 
0.002 
HIV status 
   Positive 
   Negative 
   Unknown 
 
Reference 
0.89 (0.38, 2.06) 
0.68 (0.26, 1.74) 
 
 
0.795 
0.425 
Average BP measurement 
   Controlled (<140/90mmHg) 
   8QFRQWUROOHGPP+J 
 
Reference 
1.14 (0.67, 1.94) 
 
 
0.617 
Type of medication 
   OHA 
   Insulin 
   Both 
 
Reference 
1.00 (0.42, 2.37) 
1.18 (0.65, 2.13) 
 
 
0.984 
0.586 
Muskulo-skeletal disease 
   Yes 
   No 
 
1.79 (0.81, 3.93) 
Reference 
 
0.147 
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Table 5: Multivariate logistic regression analysis of factors associated with below average 
MCS-12  
Variables Adjusted Odds Ratio (95% CI) P-value 
Gender 
   Male 
   Female 
 
Reference  
1.19 (0.68, 2.11) 
 
 
0.530 
Age in years 
   21-54 
   55-64 
   65 & above 
 
Reference  
0.56 (0.29, 1.08) 
1.26 (0.61, 2.58) 
 
 
0.085 
0.526 
Level of education 
   No formal education 
   Any primary education 
   Secondary and above 
 
1.68 (0.72, 3.90) 
1.53 (0.82,2.85) 
Reference 
 
0.223 
0.172 
Marital status 
   Never married 
   Currently married 
   Others 
 
Reference  
1.01 (0.52, 1.95) 
1.58 (0.79, 3.13) 
 
 
0.969 
0.190 
BMI 
   Non-obese (< 30kg/m2) 
   Obese NJP2) 
 
Reference 
1.10 (0.65, 1.85) 
 
 
0.707 
Documented diabetes complications    
   None 
   One  
   Two  
   Three or more  
 
Reference 
1.98 (0.90, 4.38) 
2.40 (1.09, 5.26) 
5.37 (2.41, 11.96) 
 
 
0.089 
0.028 
0.000 
HIV status 
   Positive 
   Negative 
   Unknown 
 
Reference 
1.28 (0.55, 2.97) 
1.73 (0.67, 4.43) 
 
 
0.551 
0.250  
Average BP measurement 
   Controlled (<140/90mmHg) 
   Uncontrolled PP+J 
 
Reference 
0.92 (0.54, 1.56) 
 
 
0.776 
Type of medication 
   OHA 
   Insulin 
   Both 
 
Reference 
1.78 (0.77, 4.09) 
1.37 (0.76, 2.47) 
 
 
0.170 
0.284 
Muskulo-skeletal disease 
   Yes 
   No 
 
2.52(1.15, 5.52) 
Reference 
 
0.020 
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Table 6: Health related quality of life association with CD4 among HIV positive patients 
 CD4 up to 500 
(%) 
CD4 over 500 p-value 
PCS-12 
< 50% 
below 
average 
DERYH
average 
 
5 (41.7%) 
 
 
7 (58.3%) 
 
10 (47.6%) 
 
 
11 (52.4%) 
1.00 
MCS-12 
<50% below 
average 
DERYH
average 
 
3 (25.0%) 
 
 
9 (75.0%) 
 
9 (42.9%) 
 
 
12 (57.1%) 
0.46 
* Mean CD4 is 641.58 umol/l 
 
